COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,973 Articles (22,604 medRxiv, 8,369 bioRxiv)

Most recent first Previous |  Page 773: Articles 7721-7730  | Next

Pre-morbid use of proton pump inhibitors has no effect on the risk of death or hospitalization in COVID-19 patients: a matched cohort study
Kodvanj, I., Homolak, J., Trkulja, V.
10.1101/2022.04.30.22274526 — Posted: 2022-05-01
Health-Related Quality of Life and Coping Strategies adopted by COVID-19 survivors: A nationwide cross-sectional study in Bangladesh
Hossain, M. A., Shafin, R., Ahmed, M. S., Rana, M. S., Walton, L. M., Raigangar, V., Ara, T., Rasel, M. A. H., Hossain, M. S., Kabir, M. F., Islam, M. R., Hasan, M. N., Hossain, D., Rumana, F. S., Jahid, I. K.
10.1101/2022.04.30.22274514 — Posted: 2022-05-01
Vaccine Stockpile Sharing For Selfish Objectives
Shivam, S., Weitz, J., Wardi, Y.
10.1101/2022.04.28.22274446 — Posted: 2022-05-01
Human behaviour, NPI and mobility reduction effects on COVID-19 transmission in different countries of the world
Mohammadi, Z., Cojocaru, M. G., Thommes, E. W.
10.1101/2022.04.29.22274485 — Posted: 2022-05-01
Forecast Intervals for Infectious Disease Models
Picard, R., Osthus, D.
10.1101/2022.04.29.22274494 — Posted: 2022-05-01
Effectiveness of ChAdOx1-S COVID-19 Booster Vaccination against the Omicron and Delta variants in England
Kirsebom, F., Andrews, N., Sachdeva, R., Stowe, J., Ramsay, M., Lopez Bernal, J.
10.1101/2022.04.29.22274483 — Posted: 2022-05-01
Promising efficacy of following a third dose of mRNA SARS-CoV-2 vaccination in patients treated with anti-CD20 antibody who failed 2-dose vaccination
Funakoshi, Y., Yakushijin, K., Ohji, G., Hojo, W., Sakai, H., Watanabe, M., Kitao, A., Miyata, Y., Saito, Y., Kawamoto, S., Yamamoto, K., Ito, M., Koyama, T., Imamura, Y., Kiyota, N., Matsuoka, H., Mori, Y., Minami, H.
10.1101/2022.04.28.22274174 — Posted: 2022-05-01
Multi-omics identify LRRC15 as a COVID-19 severity predictor and persistent pro-thrombotic signals in convalescence
Gisby, J. S., Buang, N. B., Papadaki, A., Clarke, C. L., Malik, T. H., Medjeral-Thomas, N., Pinheiro, D., Mortimer, P. M., Lewis, S., Sandhu, E., McAdoo, S. P., Prendecki, M. F., Willicombe, M., Pickering, M. C., Botto, M., Thomas, D. C., Peters, J. E.
10.1101/2022.04.29.22274267 — Posted: 2022-05-01
Immediate myeloid depot for SARS-CoV-2 in the human lung
Magnen, M., You, R., Rao, A. A., Davis, R. T., Rodriguez, L., Simoneau, C. R., Hysenaj, L., Hu, K. H., The UCSF COMET Consortium, , Love, C., Woodruff, P. G., Erle, D. J., Hendrickson, C. M., Calfee, C. S., Matthay, M. A., Roose, J. P., Sil, A., Ott, M., Langelier, C. R., Krummel, M. F., Looney, M. R.
10.1101/2022.04.28.489942 — Posted: 2022-04-29
Argon plasma-modified bacterial cellulose filters for protection against respiratory pathogens
Zywicka, A., Ciecholewska-Jusko, D., Szymanska, M., Drozd, R., Sobolewski, P., Junka, A., Gorgieva, S., El Fray, M., Fijalkowski, K.
10.1101/2022.04.28.489859 — Posted: 2022-04-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).